US6404911066
US6404911066
Neogen Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 31.05.2026 | Q1 '26 28.02.2026 | Q4 '25 30.11.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.59B EUR | 1.95B EUR | 2.44B EUR | 1.3B EUR |
Enterprise Value | 3.16B EUR | 2.56B EUR | 3.08B EUR | 1.95B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 28.44x | -- | -- | -- |
Price to Sales | 2.93x | 2.24x | 2.81x | 1.97x |
Price to Book | 1.23x | 0.93x | 1.16x | 0.62x |
EV/Revenue | 3.57x | 2.94x | 3.54x | 2.96x |
EV/EBITDA | 28.98x | 26.78x | 38.89x | 34.4x |
Price to FCF (P/FCF) | 66.44x | 61.22x | 400.34x | -- |
EV/FCF | 81.12x | 80.28x | 504.07x | -- |
FCF Yield | 1.51% | 1.63% | 0.25% | -0.38% |